Skip to main content
. 2017 Dec 20;5(3):249–256. doi: 10.1002/ehf2.12240

Figure 2.

Figure 2

New York Heart Association functional class at baseline and during the follow‐up in patients with Chagas disease heart failure treated with ivabradine and placebo (χ2 test).